Your browser doesn't support javascript.
loading
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.
Van Puyvelde, Sandra; de Block, Tessa; Sridhar, Sushmita; Bawn, Matt; Kingsley, Robert A; Ingelbeen, Brecht; Beale, Mathew A; Barbé, Barbara; Jeon, Hyon Jin; Mbuyi-Kalonji, Lisette; Phoba, Marie-France; Falay, Dadi; Martiny, Delphine; Vandenberg, Olivier; Affolabi, Dissou; Rutanga, Jean Pierre; Ceyssens, Pieter-Jan; Mattheus, Wesley; Cuypers, Wim L; van der Sande, Marianne A B; Park, Se Eun; Kariuki, Simon; Otieno, Kephas; Lusingu, John P A; Mbwana, Joyce R; Adjei, Samuel; Sarfo, Anima; Agyei, Seth O; Asante, Kwaku P; Otieno, Walter; Otieno, Lucas; Tahita, Marc C; Lompo, Palpouguini; Hoffman, Irving F; Mvalo, Tisungane; Msefula, Chisomo; Hassan-Hanga, Fatimah; Obaro, Stephen; Mackenzie, Grant; Deborggraeve, Stijn; Feasey, Nicholas; Marks, Florian; MacLennan, Calman A; Thomson, Nicholas R; Jacobs, Jan; Dougan, Gordon; Kariuki, Samuel; Lunguya, Octavie.
Affiliation
  • Van Puyvelde S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK. sandra.vanpuyvelde@uantwerpen.be.
  • de Block T; Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. sandra.vanpuyvelde@uantwerpen.be.
  • Sridhar S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. sandra.vanpuyvelde@uantwerpen.be.
  • Bawn M; Institute of Tropical Medicine, Antwerp, Belgium.
  • Kingsley RA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
  • Ingelbeen B; Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  • Beale MA; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA.
  • Barbé B; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Jeon HJ; Quadram Institute Bioscience, Norwich, UK.
  • Mbuyi-Kalonji L; Earlham Institute, Norwich, UK.
  • Phoba MF; Faculty of Biological Sciences, University of Leeds, Leeds, UK.
  • Falay D; Quadram Institute Bioscience, Norwich, UK.
  • Martiny D; School of Biological Science, University of East Anglia, Norwich, UK.
  • Vandenberg O; Institute of Tropical Medicine, Antwerp, Belgium.
  • Affolabi D; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Rutanga JP; Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  • Ceyssens PJ; Institute of Tropical Medicine, Antwerp, Belgium.
  • Mattheus W; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
  • Cuypers WL; International Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.
  • van der Sande MAB; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.
  • Park SE; Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Kariuki S; National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.
  • Otieno K; Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Lusingu JPA; National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.
  • Mbwana JR; Department of Pediatrics, University Hospital of Kisangani, Kisangani, Democratic Republic of the Congo.
  • Adjei S; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.
  • Sarfo A; Faculty of Medicine and Pharmacy, University of Mons (UMONS), 7000, Mons, Belgium.
  • Agyei SO; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.
  • Asante KP; Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London, UK.
  • Otieno W; Centre National Hospitalier Universitaire Hubert Koutoukou Maga, Cotonou, Benin.
  • Otieno L; Institute of Tropical Medicine, Antwerp, Belgium.
  • Tahita MC; College of Science and Technology, University of Rwanda, Kigali, Rwanda.
  • Lompo P; National Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.
  • Hoffman IF; National Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.
  • Mvalo T; Institute of Tropical Medicine, Antwerp, Belgium.
  • Msefula C; Department of Computer Science, University of Antwerp, Antwerp, Belgium.
  • Hassan-Hanga F; Institute of Tropical Medicine, Antwerp, Belgium.
  • Obaro S; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Mackenzie G; International Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.
  • Deborggraeve S; Yonsei University Graduate School of Public Health, Seodaemun-gu, Seoul, 03722, Republic of Korea.
  • Feasey N; Kenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.
  • Marks F; Kenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.
  • MacLennan CA; National Institute for Medical Research, Tanga, Tanzania.
  • Thomson NR; Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, København, Denmark.
  • Jacobs J; National Institute for Medical Research, Tanga, Tanzania.
  • Dougan G; University of Health & Allied Sciences, Ho, Volta Region, Ghana.
  • Kariuki S; University of Health & Allied Sciences, Ho, Volta Region, Ghana.
  • Lunguya O; University of Health & Allied Sciences, Ho, Volta Region, Ghana.
Nat Commun ; 14(1): 6392, 2023 10 23.
Article de En | MEDLINE | ID: mdl-37872141
ABSTRACT
Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality is responsible for a huge public health burden in sub-Saharan Africa. Salmonella enterica serovar Typhimurium (S. Typhimurium) is the main cause of iNTS disease in Africa. By analysing whole genome sequence data from 1303 S. Typhimurium isolates originating from 19 African countries and isolated between 1979 and 2017, here we show a thorough scaled appraisal of the population structure of iNTS disease caused by S. Typhimurium across many of Africa's most impacted countries. At least six invasive S. Typhimurium clades have already emerged, with ST313 lineage 2 or ST313-L2 driving the current pandemic. ST313-L2 likely emerged in the Democratic Republic of Congo around 1980 and further spread in the mid 1990s. We observed plasmid-borne as well as chromosomally encoded fluoroquinolone resistance underlying emergences of extensive-drug and pan-drug resistance. Our work provides an overview of the evolution of invasive S. Typhimurium disease, and can be exploited to target control measures.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Salmonelloses / Salmonella typhimurium Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Salmonelloses / Salmonella typhimurium Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni
...